Cannabis Tetra Bio-Pharma enters Australia via new subsidiary acquisition Canadian company set to focus clinical trials down under, announces regulatory update Rowan DunneJune 6, 2022
Business Tetra Bio-Pharma partners with Avicanna to bring cannabinoid medical products to LATAM Tetra Bio-Pharma Inc. (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) is teaming up with Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) to bring Tetra’s products... Natalia Buendia CalvilloFebruary 14, 2022
Cannabis Company study suggests inhalation of CBD safer than ingestion Tetra Bio-Pharma's results relate to other findings that high doses of CBD can cause toxicity in the liver when ingested Nick LabaAugust 28, 2020
Cannabis Tetra Bio-Pharma pens device deal with Storz & Bickel, Canopy Company says the deal is a crucial step in bringing its cancer pain treatment to market Nick LabaJune 5, 2020
COVID-19 Tetra Bio-Pharma to resume cannabis pet study after COVID-19 halted trial Company is testing similar cannabis drug to see if it can treat symptoms of COVID-19 in humans Jared GnamMay 11, 2020
COVID-19 Tetra Bio-Pharma gets 5th orphan drug status for CBD topical The company is expanding its strategy of obtaining rare drug designations for cannabis-based drugs during the pandemic Jared GnamApril 23, 2020
The weed wire Tetra Bio Pharma hires pediatric meds exec as president Sylvain Chrétien was president of Pediapharm and Medexus for 12 years Nick LabaFebruary 18, 2020
Coming soon Health Canada approves two Tetra Bio Pharma topicals for over-the-counter sales Treatments for back pain and hemorrhoids will hit shelves mid-2020, company says Nick LabaJanuary 17, 2020